Statement by Mr. François Hollande, President of the Republic, on the policy in favor of research, particularly medical research, in Paris on November 14, 2012.

France François Hollande · President of France

14 November 2012 · Inauguration of the research center on emerging diseases at the Pasteur Institute · Pasteur Institute, Paris, France

Context
Hollande addressed the Institut Pasteur in Paris on November 14, 2012, to inaugurate a new research center on emerging diseases named after Nobel laureate François Jacob.
Main themes
Medical research policy, Institut Pasteur, infectious diseases, emerging diseases research center inauguration, François Jacob tribute, biomedical research funding, vaccines and prevention, antibiotic resistance, France's research ecosystem, scientific innovation, public health
Duration
~16 min
54th percentile
Words
1,886
54th percentile
Sentences
96
61st percentile
Readability
48
56th percentile
Grade
11.5
38th percentile
Syntax
2.98
45th percentile
Vocabulary
2.19
47th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 45%45%
  • Ceremonial 23%23%
  • Economic 14%14%
  • Geopolitical 10%10%
  • Institutional 8%8%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

96 sentences in 37 paragraphs

Ladies Ministers,

Ladies and Gentlemen elected officials,

Madam Director General,

Mr. Chairman of the Board of Directors,

Ladies and Gentlemen,

I wanted to first express to you the pride that this inauguration represents for the head of state at the Pasteur Institute, this institution rich in its history, rich in its discoveries. I want to acknowledge here, of course, its leadership but also all the staff. You contribute to the radiance of France by providing, through vaccines, means of prevention to our fellow citizens and, beyond that, to the entire world.

I am inaugurating this evening a building, a large building, a research center on emerging diseases. This building bears a name, that of François JACOB. This choice is both a symbol and a tribute. The symbol is that of a double fidelity: that of a great researcher to the Pasteur Institute, but also that of this institution towards this great researcher. This tribute is paid to an exceptional individual awarded the Nobel Prize in Medicine. You have had the delicacy to associate André LWOFF, Jacques MONOD, and all those who have received this high distinction and who are "pasteurians." I want to mention Françoise BARRE-SINOUSSI here.

Dear François JACOB, a life cannot be divided; there is not the researcher and the resistance fighter, there is the entirety of what constitutes a destiny. Yours is a sum of convictions. This building bears your name because you are a great researcher but also because you are a man who mattered for the liberation of Paris and France. You committed yourself to the Free French Forces, in the 2nd DB, and you became one of the Companions of the Liberation. There are only twenty-three survivors left to honor the memory of those who dedicated themselves to this fight alongside General de GAULLE. It is a privilege given to each and every one of you present this evening to be able to meet François JACOB.

The Pasteur Institute is a source of pride for France and a reference in the world because you have managed, generation after generation, leadership after leadership, to both elevate the sense of innovation to the highest level and at the same time respect your own history, History.

Almost 124 years ago, Louis PASTEUR assigned three objectives to the Institute he created: "to be a dispensary for the treatment of rabies; a research center for infectious diseases; a teaching center for studies related to microbes."

The first of the missions -- rabies -- unless one thinks it may have affected a certain number of human beings in another form, that battle has been won. The third has changed in meaning, form, and aspect; I want to speak of what relates to microbes. However, the vocation defined by PASTEUR more than a century ago -- to be a research center for infectious diseases -- remains and is pursued -- with what talent! -- today. It is this vocation that brings us together today.

The building we are inaugurating this evening, after six years of work -- thanks to the mobilization of the state, local authorities, but also private companies that I want to acknowledge -- this great work will host 400 researchers. Its exceptional size -- 16,000 m² -- its infrastructure and its materials are of excellence because it is about fighting against a humanitarian scourge.

Infectious diseases continue to kill 14 million people each year worldwide, despite advances in medicine. These diseases are now the leading cause of mortality among children and young adults. This is therefore an urgent matter.

But research, on the other hand, is a long-term endeavor.

How to address the immediate and prepare for the future? This is your fight. In this battle, you do not precisely know your enemy. You seek it out, you flush it out, and sometimes fortunately you find it.

How indeed can one predict the emergence of a new infectious disease? How to imagine its expression, its magnitude? But also, how to fight against antibiotic resistance? The new laboratories we are opening this evening will be the theater of this constant confrontation -- between science on one side and disease on the other -- to find, for example, vaccines against malaria, hepatitis C, and AIDS. I know that many here are actors in this battle and this commitment. They can be assured that here, at the Pasteur Institute, everything will be done in this direction.

France expects a lot from biomedical research. This research is organized around very high-quality structures: the Pasteur Institute of course, but also universities, university hospital centers, INSERM, CNRS, CEA, IRD, CIRAD. We have a whole constellation of major organizations that can participate in the research effort and at the same time provide us with conditions for our economic development.

This is therefore a considerable asset for our country. If we include the so-called biotechnology sectors, this sector represents 600,000 direct and indirect jobs. 7.5 billion euros are invested each year in research, shared equally between major public organizations and health industries. There is much talk about the GALLOIS report. What does it have to do with the Pasteur Institute? Among the major sectors it indicates for the economic development of our country, for its competitiveness, it places health and the life economy at the forefront of our major investment priorities, and we will once again follow it in this direction.

French research has just been recognized again through the awarding of the Nobel Prize in Physics to Professor Serge HAROCHE. I had the pleasure of meeting him. He came with his team, which is already the generation preparing for his succession, he himself being ready to pass the baton.

There were young researchers with him who had gone through a whole path of excellence, such as that of the École Normale Supérieure, and produced great scientific works, with salaries that have nothing to do with those found in finance or banking. I asked these young French and foreign researchers. They told me they believed in what they were doing and that they also asked for recognition, consideration, and attention. Serge HAROCHE himself told me there was an expectation, among many others, the expectation for simplification.

Our structures, and Madam Minister of Research knows this, are too numerous, the funding mechanisms are not coordinated enough, the evaluation processes are too burdensome when they do not overlap. This means that the effectiveness and even the visibility of our research on the international level are not as great as we deserve.

I have therefore asked the government and the minister responsible for this issue in particular, to take all practical measures, all legal means, within the framework of a new research bill, to allow for better organization of research and particularly biomedical research.

What we need to ensure is the breaking down of silos. This will be the key word of the reform, and it applies not only in this area: breaking down silos between all forms of research - fundamental, transdisciplinary, "finalized," applied - which must enrich each other; breaking down silos between universities and grandes écoles, research centers, industry, hospitals -- Madam Minister of Social Affairs will ensure this; breaking down silos also between public research and private research, which must learn from each other.

The state is resolved to this, because it is both an obligation in terms of our research results, trust in our researchers, and at the same time it is also the means to be even more efficient for our industries.

France, because it is France, must look beyond itself. Beyond the present time.

The challenge of biomedical research is to know how to develop, and you are here an illustration of this will, at the international level. Once again, the Pasteur Institute sets an example: 32 institutes around the world, in Africa, South America, Southeast Asia. I recently went to Laos, where there was a large meeting bringing together European and Asian countries. Laos, a small country with many difficulties, and whose greatest pride was to host a laboratory of the Pasteur Institute where there were French researchers but also Laotian researchers and others coming from further away, working together precisely to ensure that we can fight against these emerging diseases.

This is the spirit we must instill everywhere. It is an obligation to act at the international level because viruses do not know borders and do not stop.

Looking beyond ourselves means looking towards Europe. There is so much to say about Europe, and we say so much that we end up forgetting the essential, which is that Europe, beyond what it has already done for peace and for part of our prosperity, is also a space for research. There is a program "Horizon 2020" which aims precisely to consolidate, or even expand, the common research space.

I call on our major institutions, our researchers, to fully grasp this new dimension of research funding and to participate in all European calls for proposals. We are, according to the usual jargon used in Europe, net contributors, due to a lack of responses, even though our success rate, whenever we compete, is above average. This means that we are not seeking all the funding that exists at the European level to put it to the service of our own research.

France must look beyond itself; it must also look towards emerging countries that need the excellence we can offer them in terms of research; they also need our solidarity.

In the countries of the South, infectious diseases account for 43% of causes of mortality compared to 1% in industrialized countries because illness adds to all other inequalities, and those who cannot afford treatment are often, are always, the poorest.

Sub-Saharan Africa is facing malaria, tuberculosis, AIDS. This Africa asks us to have confidence in it, in its destiny, in its development. Africa will be the continent of tomorrow. We must contribute to helping these populations who sometimes live with suffering to the point of dying. We will help the countries concerned to have, thanks to you, thanks to the Pasteur Institute, the most suitable tools for prevention, diagnosis, and therapies.

The Pasteur Institute has expatriate staff in a large number of developing countries - and I want to acknowledge them here. Thanks to their work, they disseminate expertise, training, but also the spirit of research.

You also welcome foreign researchers. Welcome to foreign researchers in France! They have their place, and we must give them the best welcome because here, at the Pasteur Institute, you pursue one of the most beautiful missions that can be pursued by an institution, as researchers, as doctors, as administrative staff, and I do not forget the teachers: you have the mission to heal, care, prevent, and soothe.

The responsibility of the state is to give you the means to meet this requirement.

The François JACOB building embodies this beautiful ambition of France capable of this achievement. I want to summarize this ambition: to give research the means to advance science because we must trust science and, through science, advance humanity.

So thank you to PASTEUR, to the one who created this institution! Thank you to the "pasteurians," thank you to François JACOB, and thank you to all those who contribute in their own way to the development and radiance of French research!